Literature DB >> 533694

Suppressive effect of alcoholic liver disease sera on lymphocyte transformation.

G P Young, F J Dudley, M B Van Der Weyden.   

Abstract

The effect of alcoholic patient sera on in vitro lymphocyte transformation was studied using mitogen-induced uptake of (3)H-thymidine to measure blastogenesis. With pokeweed mitogen as the stimulus, transformation of normal lymphocytes in sera of alcoholics with either normal or fatty livers was not significantly different from that obtained in pooled human serum (PHS). However, in sera of patients with either alcoholic hepatitis or inactive cirrhosis mean transformation was significantly reduced (P <0.001, <0.02 respectively). With phytohaemagglutinin-P or concanavalin A as mitogens, suppression of transformation was not as marked but followed the same pattern. A significant negative correlation was observed between the magnitude of transformation and serum bilirubin and aspartate aminotransferase levels. An intra-patient comparison of the effects on transformation of normal lymphocytes by simultaneously collected peripheral and portal venous sera, and of peripheral sera obtained before and after portasystemic shunt surgery, indicated that the factor(s) responsible did not originate in the splanchnic circulation nor did it accumulate in the serum because of failed hepatic clearance. By performing transformation experiments in the presence of inhibitory patient sera diluted with PHS it was possible to show that these sera caused true inhibition of transformation rather than suppression due to failure to sustain cell culture because of nutritional deficiencies. Inhibitory sera did not contain high levels of the enzyme thymidine phosphorylase and did not significantly inhibit binding of (125)I-labelled mitogens to the lymphocyte surface. These findings indicate that the inhibitory effect of sera from alcoholics is of potential in vivo importance, that the effect increases with the degree of heptocyte damage, and that it is unrelated to the nonhepatic metabolic affects of chronic alcoholism.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 533694      PMCID: PMC1412712          DOI: 10.1136/gut.20.10.833

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  26 in total

1.  Transient suppression of the humoral immune response mediated by a factor derived from specifically activated, doubly primed lymphoid cells.

Authors:  K E Kempf; A S Rubin
Journal:  J Immunol       Date:  1977-08       Impact factor: 5.422

2.  Identification and comparative analysis of thymidine phosphorylase in the plasma of healthy subjects and cancer patients.

Authors:  J L Pauly; M G Schuller; A A Zelcer; T A Kirss; S S Gore; M J Germain
Journal:  J Natl Cancer Inst       Date:  1977-06       Impact factor: 13.506

3.  Delayed hypersensitivity in alcoholic cirrhosis.

Authors:  B Straus; M R Berenyi; J M Huang; E Straus
Journal:  Am J Dig Dis       Date:  1971-06

4.  Suppression of leukocytic mitosis by sera of hepatitis-implicated donors.

Authors:  B A Mella; H F Taswell
Journal:  Am J Clin Pathol       Date:  1970-02       Impact factor: 2.493

5.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

6.  Metabolic and hepatic effects of alcohol.

Authors:  H L Bleich; E S Boro
Journal:  N Engl J Med       Date:  1977-03-17       Impact factor: 91.245

Review 7.  Liver disease of the alcoholic: role of immunologic abnormalities in pathogenesis, recognition, and treatment.

Authors:  C M Leevy; T Chen; A Luisada-Opper; N Kanagasundaram; R Zetterman
Journal:  Prog Liver Dis       Date:  1976

8.  Studies on the subpopulation and function of peripheral lymphocytes, and inhibitor to PHA stimulation existing in the serum of patients with liver disease.

Authors:  M Nakao; Y Mizoguchi; T Monna; S Yamamoto; S Morisawa
Journal:  Gastroenterol Jpn       Date:  1975

9.  Serum inhibitory factors (SIF) in patients with acute and chronic hepatitis and their clinical significance.

Authors:  N Brattig; P A Berg
Journal:  Clin Exp Immunol       Date:  1976-07       Impact factor: 4.330

10.  Lymphopenia and lymphocyte transformation in alcoholics.

Authors:  G P Young; M B Van der Weyden; I S Rose; F J Dudley
Journal:  Experientia       Date:  1979-02-15
View more
  5 in total

1.  Clostridium tertium bacteremia in a leukemia patient.

Authors:  D A Leichtman; W D LeBar
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-04       Impact factor: 3.267

2.  T-lymphocyte activation pathways in alcoholic liver disease.

Authors:  F Spinozzi; A Bertotto; F Rondoni; R Gerli; F Scalise; F Grignani
Journal:  Immunology       Date:  1991-06       Impact factor: 7.397

3.  Deficient natural killer cell activity in alcoholic cirrhosis.

Authors:  B Charpentier; D Franco; L Paci; M Charra; B Martin; D Vuitton; D Fries
Journal:  Clin Exp Immunol       Date:  1984-10       Impact factor: 4.330

4.  Histologic and systemic prognosticators for local control and survival in margin-negative transoral laser microsurgery treated oral cavity squamous cell carcinoma.

Authors:  Parul Sinha; Mitra Mehrad; Rebecca D Chernock; James S Lewis; Samir K El-Mofty; Ningying Wu; Brian Nussenbaum; Bruce H Haughey
Journal:  Head Neck       Date:  2014-01-16       Impact factor: 3.147

5.  Demonstration of non-specific B-cell stimulation in patients with cirrhosis.

Authors:  G Holdstock; W B Ershler; E L Krawitt
Journal:  Gut       Date:  1982-09       Impact factor: 23.059

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.